Ubiquitination during infection with Mouse Adenovirus
Ubiquitination during infection with Mouse Adenovirus
批准号:
10152932
负责人:
Matthew D. Weitzman
金额:
$22.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-04 至 2023-02-28
关键词:
Adenovirus InfectionsAdenovirusesAntiviral AgentsAutomobile DrivingCell physiologyCellsComplexCullin ProteinsDNADNA DamageDNA VirusesDataGeneticGoalsHost DefenseHumanInfectionInnate Immune ResponseIntegration Host FactorsInterferonsLATS1 geneLeadLigaseMediatingModelingMolecularMouse ProteinMusNuclearNucleic AcidsOrthologous GenePathway interactionsProcessProductionProteinsProteomeProteomicsRNAReportingResourcesRoleSeminalSignal TransductionSpecies SpecificitySubstrate SpecificitySystemTimeUbiquitinUbiquitinationViralViral PathogenesisViral ProteinsVirusVirus DiseasesYWHAQ genearmbasecellular targetinginnate immune pathwaysinnate immune sensinginsightmembermulticatalytic endopeptidase complexmultidisciplinaryresponsesensorubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Viruses exert an extensive network of dynamic interactions with host components to promote infection by
dismantling cellular intrinsic and innate defenses. A central arm of viral takeover of cellular processes relies on
viral exploitation of the cellular ubiquitin system to induce degradation of host factors. However, there is a gap
in our understanding of the molecular mechanisms by which ubiquitin is harnessed by viral proteins. Here we
propose a cross-species comparison of the human and mouse adenovirus systems to explore how viruses
subvert host defenses via ubiquitin. Human adenovirus 5 (HAd5) is a prominent nuclear-replicating DNA virus
that redirects cellular Cullin E3 ubiquitin ligase activity via complex formation with two viral early proteins
(E1B55K and E4orf6). We recently developed a proteomics approach to define host proteins ubiquitinated when
the HAd5 E1B55K/E4orf6 complex is expressed. By combining our ubiquitome analysis with whole cell
proteomics, we were able to define which substrates are ubiquitinated and which are subsequently degraded as
a result of the E1B55K/E4orf6 complex. The strict species-specificity of adenovirus infection limits our ability to
study HAd in its natural host, but mouse adenovirus type 1 (MAV-1) provides an alternative tractable system.
Based on genetic similarities, MAV-1 is thought to encode orthologs (mE1B55K and mE4orf6) to the HAd5
complex, and these proteins are presumed to redirect cellular ubiquitin in a parallel fashion. We have applied
our proteomics pipeline to MAV-1 infected cells, and used global ubiquitin-profiling to identify proteins modified
and degraded by the virus. Distinct from HAd5, we discovered that MAV-1 uniquely facilitates degradation of
several canonical and non-canonical proteins involved in nucleic acid sensing and antiviral interferon signaling,
including PKR and STING. Contrary to the prevailing dogma of how the HAd5 E1B55K/E4orf6 complex employs
the E1B55K component to select ubiquitination substrates, we surprisingly discovered that mE4orf6 is sufficient
to reduce abundance of the antiviral RNA sensor PKR in a proteasome- and Cullin- dependent manner,
independent of mE1B55K. These findings collectively suggest divergence in the composition, mechanisms of
assembly, and substrate selectivity between the HAd5 and MAV-1 directed E3 ligases. An overarching
implication is that the MAV-1 and HAd5 complex exploit ubiquitin in different ways to counteract intrinsic and
innate immune responses. In Aim 1 we will leverage a multidisciplinary, quantitative proteomics approach to
systematically define the endogenous cellular ubiquitin substrates and associated pathways targeted during
MAV-1 infection. We will also determine the functional consequences of substrate ubiquitination during infection.
In Aim 2 we will establish the composition, and mechanisms of substrate selection for the MAV-1 directed E3
ligase complex and compare to HAd5. Results of our cross-species comparisons will provide insights into both
core principles and distinct strategies that govern how adenoviruses exploit cellular ubiquitin to dismantle host
defenses and facilitate viral pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-canonical chimeric proteins generated during Adenovirus infection
-
批准号:10448505
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Matthew D. Weitzman
-
依托单位:
Non-canonical chimeric proteins generated during Adenovirus infection
-
批准号:10312411
-
项目类别:
-
资助金额:$22.0万
-
财政年份:2021
-
负责人:Matthew D. Weitzman
-
依托单位:
Ubiquitination during infection with Mouse Adenovirus
-
批准号:10364682
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2021
-
负责人:Matthew D. Weitzman
-
依托单位:
Double-stranded RNA during DNA virus infection
-
批准号:9886201
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2019
-
负责人:Matthew D. Weitzman
-
依托单位:
Double-stranded RNA during DNA virus infection
-
批准号:10092100
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2019
-
负责人:Matthew D. Weitzman
-
依托单位:
Double-stranded RNA during DNA virus infection
-
批准号:10359055
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2019
-
负责人:Matthew D. Weitzman
-
依托单位:
Double-stranded RNA during DNA virus infection
-
批准号:9764127
-
项目类别:
-
资助金额:$62.38万
-
财政年份:2019
-
负责人:Matthew D. Weitzman
-
依托单位:
Double-stranded RNA during DNA virus infection
-
批准号:10571919
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2019
-
负责人:Matthew D. Weitzman
-
依托单位:
Adenovirus manipulation of cellular chromatin to overcome host responses
-
批准号:10238103
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Matthew D. Weitzman
-
依托单位:
Adenovirus manipulation of cellular chromatin to overcome host responses
-
批准号:9979734
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Matthew D. Weitzman
-
依托单位:
Adenovirus manipulation of cellular chromatin to overcome host responses
-
批准号:9790957
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Matthew D. Weitzman
-
依托单位:
Adenovirus manipulation of cellular chromatin to overcome host responses
-
批准号:10457368
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2018
-
负责人:Matthew D. Weitzman
-
依托单位:
Identifying proteins involved in virus DNA replication
-
批准号:9034220
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2016
-
负责人:Matthew D. Weitzman
-
依托单位:
Identifying proteins involved in virus DNA replication
-
批准号:9198945
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2016
-
负责人:Matthew D. Weitzman
-
依托单位:
Exploring the oncogenic potential of human APOBEC3 cytosine deaminases
-
批准号:8876242
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2015
-
负责人:Matthew D. Weitzman
-
依托单位:
Role of DNA damage in the early steps of HSV infection and latency in neurons
-
批准号:8990090
-
项目类别:
-
资助金额:$5.49万
-
财政年份:2015
-
负责人:Matthew D. Weitzman
-
依托单位:
The human APOBEC3A deaminase - genomic instability and regulation
-
批准号:8759781
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2014
-
负责人:Matthew D. Weitzman
-
依托单位:
3rd ASM Conference on Viral Manipulation of Nuclear Processes
-
批准号:8837748
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2014
-
负责人:Matthew D. Weitzman
-
依托单位:
The human APOBEC3A deaminase - genomic instability and regulation
-
批准号:8895289
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2014
-
负责人:Matthew D. Weitzman
-
依托单位:
The human APOBEC3A deaminase - genomic instability and regulation
-
批准号:9302704
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2014
-
负责人:Matthew D. Weitzman
-
依托单位:
海外基金